AU763197B2 - Iontophoretic drug delivery electrodes - Google Patents
Iontophoretic drug delivery electrodes Download PDFInfo
- Publication number
- AU763197B2 AU763197B2 AU40966/99A AU4096699A AU763197B2 AU 763197 B2 AU763197 B2 AU 763197B2 AU 40966/99 A AU40966/99 A AU 40966/99A AU 4096699 A AU4096699 A AU 4096699A AU 763197 B2 AU763197 B2 AU 763197B2
- Authority
- AU
- Australia
- Prior art keywords
- medicament
- electrode
- individual
- skin
- substrate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 238000012377 drug delivery Methods 0.000 title claims description 6
- 239000003814 drug Substances 0.000 claims description 177
- 210000004027 cell Anatomy 0.000 claims description 74
- 239000010410 layer Substances 0.000 claims description 24
- 238000011282 treatment Methods 0.000 claims description 22
- 230000003902 lesion Effects 0.000 claims description 18
- 238000004891 communication Methods 0.000 claims description 13
- 238000000034 method Methods 0.000 claims description 13
- 239000000203 mixture Substances 0.000 claims description 12
- 230000037317 transdermal delivery Effects 0.000 claims description 11
- 238000009472 formulation Methods 0.000 claims description 10
- 239000000853 adhesive Substances 0.000 claims description 9
- 230000001070 adhesive effect Effects 0.000 claims description 9
- 230000000694 effects Effects 0.000 claims description 9
- 239000000463 material Substances 0.000 claims description 9
- 239000004020 conductor Substances 0.000 claims description 8
- 208000002874 Acne Vulgaris Diseases 0.000 claims description 7
- 206010000496 acne Diseases 0.000 claims description 7
- MKUXAQIIEYXACX-UHFFFAOYSA-N aciclovir Chemical compound N1C(N)=NC(=O)C2=C1N(COCCO)C=N2 MKUXAQIIEYXACX-UHFFFAOYSA-N 0.000 claims description 6
- 239000012530 fluid Substances 0.000 claims description 6
- 208000001688 Herpes Genitalis Diseases 0.000 claims description 5
- 239000003443 antiviral agent Substances 0.000 claims description 5
- 201000004946 genital herpes Diseases 0.000 claims description 5
- 239000011159 matrix material Substances 0.000 claims description 5
- 239000012790 adhesive layer Substances 0.000 claims description 4
- 201000010099 disease Diseases 0.000 claims description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 4
- 229920001971 elastomer Polymers 0.000 claims description 4
- 239000000806 elastomer Substances 0.000 claims description 4
- 210000000707 wrist Anatomy 0.000 claims description 4
- 230000036571 hydration Effects 0.000 claims description 3
- 238000006703 hydration reaction Methods 0.000 claims description 3
- 230000001939 inductive effect Effects 0.000 claims description 3
- 238000002203 pretreatment Methods 0.000 claims description 2
- 230000001225 therapeutic effect Effects 0.000 claims description 2
- 239000000758 substrate Substances 0.000 claims 50
- 210000003491 skin Anatomy 0.000 claims 46
- 150000008040 ionic compounds Chemical class 0.000 claims 4
- 208000004898 Herpes Labialis Diseases 0.000 claims 3
- 210000003850 cellular structure Anatomy 0.000 claims 2
- 210000004207 dermis Anatomy 0.000 claims 2
- 239000012212 insulator Substances 0.000 claims 2
- 125000000129 anionic group Chemical group 0.000 claims 1
- 230000005540 biological transmission Effects 0.000 claims 1
- 125000002091 cationic group Chemical group 0.000 claims 1
- 230000008878 coupling Effects 0.000 claims 1
- 238000010168 coupling process Methods 0.000 claims 1
- 238000005859 coupling reaction Methods 0.000 claims 1
- 230000000887 hydrating effect Effects 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 claims 1
- 229940079593 drug Drugs 0.000 description 12
- 210000001519 tissue Anatomy 0.000 description 12
- 230000008901 benefit Effects 0.000 description 8
- 239000011148 porous material Substances 0.000 description 7
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical group C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 5
- 229960004150 aciclovir Drugs 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 238000010276 construction Methods 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 229920002379 silicone rubber Polymers 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 208000000260 Warts Diseases 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 230000000774 hypoallergenic effect Effects 0.000 description 3
- 150000002500 ions Chemical class 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 230000035515 penetration Effects 0.000 description 3
- 229920001296 polysiloxane Polymers 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 201000010153 skin papilloma Diseases 0.000 description 3
- 230000000699 topical effect Effects 0.000 description 3
- 229920000742 Cotton Polymers 0.000 description 2
- 208000009889 Herpes Simplex Diseases 0.000 description 2
- 208000031888 Mycoses Diseases 0.000 description 2
- 201000004681 Psoriasis Diseases 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 230000005661 hydrophobic surface Effects 0.000 description 2
- 230000003463 hyperproliferative effect Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 229920000260 silastic Polymers 0.000 description 2
- 238000004381 surface treatment Methods 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 230000009885 systemic effect Effects 0.000 description 2
- 238000013271 transdermal drug delivery Methods 0.000 description 2
- QBWKPGNFQQJGFY-QLFBSQMISA-N 3-[(1r)-1-[(2r,6s)-2,6-dimethylmorpholin-4-yl]ethyl]-n-[6-methyl-3-(1h-pyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-1,2-thiazol-5-amine Chemical compound N1([C@H](C)C2=NSC(NC=3C4=NC=C(N4C=C(C)N=3)C3=CNN=C3)=C2)C[C@H](C)O[C@H](C)C1 QBWKPGNFQQJGFY-QLFBSQMISA-N 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 201000004569 Blindness Diseases 0.000 description 1
- 206010008342 Cervix carcinoma Diseases 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- 206010017533 Fungal infection Diseases 0.000 description 1
- 206010019973 Herpes virus infection Diseases 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 206010060862 Prostate cancer Diseases 0.000 description 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 description 1
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 230000003602 anti-herpes Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 239000012503 blood component Substances 0.000 description 1
- 230000036765 blood level Effects 0.000 description 1
- 201000010881 cervical cancer Diseases 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000000306 component Substances 0.000 description 1
- 229940125846 compound 25 Drugs 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 239000013583 drug formulation Substances 0.000 description 1
- 210000005069 ears Anatomy 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 230000005684 electric field Effects 0.000 description 1
- 229960004396 famciclovir Drugs 0.000 description 1
- 239000002657 fibrous material Substances 0.000 description 1
- 210000004392 genitalia Anatomy 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 150000002433 hydrophilic molecules Chemical class 0.000 description 1
- 230000005660 hydrophilic surface Effects 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- -1 hydroxyl ions Chemical class 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 230000036407 pain Effects 0.000 description 1
- 230000009984 peri-natal effect Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 230000010287 polarization Effects 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 231100000245 skin permeability Toxicity 0.000 description 1
- 229910000679 solder Inorganic materials 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000011421 subcutaneous treatment Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000003319 supportive effect Effects 0.000 description 1
- 238000011200 topical administration Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 229940107931 zovirax Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/20—Applying electric currents by contact electrodes continuous direct currents
- A61N1/30—Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Electrotherapy Devices (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/153,640 US6148231A (en) | 1998-09-15 | 1998-09-15 | Iontophoretic drug delivery electrodes and method |
| US09/153640 | 1998-09-15 | ||
| US09/205751 | 1998-12-04 | ||
| US09/205,751 US6385487B1 (en) | 1996-05-08 | 1998-12-04 | Methods for electrokinetic delivery of medicaments |
| PCT/US1999/011440 WO2000015120A1 (en) | 1998-09-15 | 1999-05-24 | Iontophoretic drug delivery electrodes |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU4096699A AU4096699A (en) | 2000-04-03 |
| AU763197B2 true AU763197B2 (en) | 2003-07-17 |
Family
ID=26850728
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU40966/99A Ceased AU763197B2 (en) | 1998-09-15 | 1999-05-24 | Iontophoretic drug delivery electrodes |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP1121059A4 (enExample) |
| JP (1) | JP4297401B2 (enExample) |
| AU (1) | AU763197B2 (enExample) |
| CA (1) | CA2343893C (enExample) |
| WO (1) | WO2000015120A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6792306B2 (en) * | 2000-03-10 | 2004-09-14 | Biophoretic Therapeutic Systems, Llc | Finger-mounted electrokinetic delivery system for self-administration of medicaments and methods therefor |
| US6477410B1 (en) * | 2000-05-31 | 2002-11-05 | Biophoretic Therapeutic Systems, Llc | Electrokinetic delivery of medicaments |
| US20040236269A1 (en) * | 2002-09-25 | 2004-11-25 | Marchitto Kevin S. | Microsurgical tissue treatment system |
| ATE384318T1 (de) | 2004-05-28 | 2008-02-15 | Geest Jan De | Kommunikationseinheit für die haut einer person |
| CA2663474C (en) | 2006-09-15 | 2017-06-27 | Griffith University | Pro-oxidant anti-cancer compounds |
| WO2017106815A1 (en) * | 2015-12-17 | 2017-06-22 | Hg Medical Technologies Llc | Electro kinetic transdermal and trans mucosal delivery accelerator device |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5458567A (en) * | 1991-06-11 | 1995-10-17 | Deknatel Technology Corp. | Collection device |
| US5658247A (en) * | 1993-04-07 | 1997-08-19 | Henley; Julian L. | Ionosonic drug delivery apparatus |
| US5676648A (en) * | 1996-05-08 | 1997-10-14 | The Aps Organization, Llp | Iontophoretic drug delivery apparatus and method for use |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US279524A (en) * | 1883-06-19 | Thimble | ||
| US3163166A (en) * | 1961-04-28 | 1964-12-29 | Colgate Palmolive Co | Iontophoresis apparatus |
| US4838273A (en) * | 1979-04-30 | 1989-06-13 | Baxter International Inc. | Medical electrode |
| US4856188A (en) * | 1984-10-12 | 1989-08-15 | Drug Delivery Systems Inc. | Method for making disposable and/or replenishable transdermal drug applicators |
| US4765343A (en) * | 1985-01-29 | 1988-08-23 | Biosonics, Inc. | Apparatus for transferring electrical energy to and from living tissue |
| JPH0647026B2 (ja) * | 1986-07-11 | 1994-06-22 | 美智士 谷 | 電磁気治療器 |
| JPS63135179A (ja) * | 1986-11-26 | 1988-06-07 | 立花 俊郎 | 薬物の経皮投与具 |
| IL86076A (en) * | 1988-04-14 | 1992-12-01 | Inventor S Funding Corp Ltd | Transdermal drug delivery device |
| JP2788307B2 (ja) * | 1989-11-30 | 1998-08-20 | 住友ベークライト株式会社 | 薬剤投与器 |
| US5589563A (en) | 1992-04-24 | 1996-12-31 | The Polymer Technology Group | Surface-modifying endgroups for biomedical polymers |
| JPH0591693U (ja) * | 1992-05-22 | 1993-12-14 | 恒 福村 | 電気治療器具 |
| US5458569A (en) * | 1993-06-08 | 1995-10-17 | Becton Dickinson And Company | Wearable iontophoresis system |
| JP2818999B2 (ja) * | 1993-11-22 | 1998-10-30 | ドラッグ デリバリー システムズ インコーポレイテッド | 経皮薬剤アプリケータ |
| JPH07194711A (ja) * | 1993-12-28 | 1995-08-01 | Tokyo Iken Kk | 電気治療器用手袋 |
| JPH09103496A (ja) * | 1995-10-12 | 1997-04-22 | Etsuko Nozoe | イオン浸透治療器 |
-
1999
- 1999-05-24 CA CA002343893A patent/CA2343893C/en not_active Expired - Fee Related
- 1999-05-24 AU AU40966/99A patent/AU763197B2/en not_active Ceased
- 1999-05-24 WO PCT/US1999/011440 patent/WO2000015120A1/en not_active Ceased
- 1999-05-24 EP EP99924478A patent/EP1121059A4/en not_active Withdrawn
- 1999-05-24 JP JP2000569706A patent/JP4297401B2/ja not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5458567A (en) * | 1991-06-11 | 1995-10-17 | Deknatel Technology Corp. | Collection device |
| US5658247A (en) * | 1993-04-07 | 1997-08-19 | Henley; Julian L. | Ionosonic drug delivery apparatus |
| US5676648A (en) * | 1996-05-08 | 1997-10-14 | The Aps Organization, Llp | Iontophoretic drug delivery apparatus and method for use |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2000015120A8 (en) | 2001-10-04 |
| EP1121059A1 (en) | 2001-08-08 |
| AU4096699A (en) | 2000-04-03 |
| JP2002524184A (ja) | 2002-08-06 |
| WO2000015120A1 (en) | 2000-03-23 |
| CA2343893C (en) | 2008-12-30 |
| EP1121059A4 (en) | 2006-04-05 |
| CA2343893A1 (en) | 2000-03-23 |
| JP4297401B2 (ja) | 2009-07-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6148231A (en) | Iontophoretic drug delivery electrodes and method | |
| US6385487B1 (en) | Methods for electrokinetic delivery of medicaments | |
| US5879323A (en) | Method for iontophoretic delivery of antiviral agents | |
| US5908401A (en) | Method for iontophoretic delivery of antiviral agents | |
| USRE37796E1 (en) | Methods for iontophoretic delivery of antiviral agents | |
| CN1607970B (zh) | 皮肤贴片 | |
| US6553253B1 (en) | Method and system for electrokinetic delivery of a substance | |
| US20130253412A1 (en) | Roller-ball applicator for transdermal iontophoretic delivery | |
| KR200403033Y1 (ko) | 피부팩용 휴대형 피부미용기기 | |
| WO1998013100A1 (en) | Iontophoretic drug delivery system, including unit for dispensing patches | |
| AU763197B2 (en) | Iontophoretic drug delivery electrodes | |
| AU2336992A (en) | Method and apparatus for treating tissue | |
| JP2003516828A (ja) | イオン導入治療システム | |
| KR100899100B1 (ko) | 피부 관리기 | |
| EP1390099B1 (en) | System for electrokinetic delivery of a substance | |
| KR20090009330U (ko) | 갈바니이온영동도입기능을 갖는 화장품용기 | |
| KR20090090057A (ko) | 갈바닉 이온도입 기능을 갖는 화장품용기 | |
| KR20230091270A (ko) | 미세전류를 활용해 피부세포를 자극함으로써 안티에이징 효과를 극대화한 콜라겐 생성 휴대용 미용기기 | |
| CA2561340A1 (en) | Electrically assisted delivery system for administration of ionized active agents | |
| HK1062414B (en) | System for electrokinetic delivery of a substance | |
| AU2001257289A1 (en) | Method and system for electrokinetic delivery of a substance | |
| KR20090095947A (ko) | 이온토포레시스도입기능을 갖는 화장품용기 | |
| AU2007216942A1 (en) | Method and system for electrokinetic delivery of a substance |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGA | Letters patent sealed or granted (standard patent) |